Article
Predicting tumor mutation burden and VHL mutation from renal cancer pathology slides with self-supervised deep learning.
Cancer medicine - 1 Aug 2024
Zheng Qingyuan, Wang Xinyu, Yang Rui, Fan Junjie, Yuan Jingping, Liu Xiuheng, Wang Lei, Xiao Zhuoni, Chen Zhiyuan
Abstract excerpt
BACKGROUND: Tumor mutation burden (TMB) and VHL mutation play a crucial role in the management of patients with clear cell renal cell carcinoma (ccRCC), such as guiding adjuvant chemotherapy and improving clinical outcomes. However, the time-consuming and expensive high-throughput sequencing methods severely limit their clinical applicability. Predicting intratumoral heterogeneity poses significant challenges in...
Topics
Join the communities discussing this publication.
